Two other H.I.V. vaccine trials, Nos. 705 and 706, known as Imbokodo and Mosaico, are still underway.

被称为 Imbokodo 和 Mosaico 的 705 和 706 仍在进行中。

Imbokodo is enrolling women in five southern African countries, and Mosaico is enrolling gay men and some transgender individuals in Europe and North America.

Imbokodo 正在南部非洲的五个国家招募女性，而 Mosaico 正在欧洲和北美招募男同性恋者和一些变性人。